Molecular Dynamics Platforms: From Computational Tools to AI-Native Simulation Infrastructure

In the frontier fields of synthetic biology, drug discovery, and materials science, researchers have long faced a core challenge: the macroscopic properties of matter—protein folding conformations, enzyme catalytic activity, material mechanical strength—are fundamentally determined by atomic-scale motions. However, the atomic scale is extremely small and evolution is extremely fast, making it difficult for traditional experiments to capture in real time. Molecular Dynamics (MD) simulation is one of the core computational approaches to address this challenge—by solving Newton's equations of motion at the atomic scale, it simulates the dynamic trajectories of atoms and molecules over time, providing important theoretical foundations for elucidating microscopic mechanisms.

The global molecular dynamics simulation industry continues to expand. According to TechSci Research, the global molecular dynamics simulation software market was valued at approximately $662 million in 2025 and is projected to grow to $1.536 billion by 2031. Separately, GIR (Global Info Research) estimates that global molecular dynamics software licensing revenue reached approximately $58.8 million in 2025 (the two sources adopt different statistical scopes). The core driver supporting this growth is the deep integration of AI technology with molecular dynamics simulation frameworks.

I. What Is a Molecular Dynamics Platform: From "Computational Tool" to "R&D Infrastructure"

Multi-Agent Autonomous Simulation Ecosystem

A molecular dynamics platform is an integrated computational R&D infrastructure that combines MD simulation engines, force field parameter libraries, trajectory analysis tools, and 3D visualization systems. Its core value lies in constructing high-precision atomic-scale 3D models within computers, relying on classical mechanics and statistical mechanics to simulate atomic motions across multiple time scales—from nanosecond-scale side-chain fluctuations to microsecond-scale conformational rearrangements—and to predict key parameters such as material mechanical properties, protein conformational evolution, and drug-target binding affinities.

Traditional MD simulations have long suffered from three major pain points. First, high operational barriers: model construction, force field selection, parameter tuning, program execution, log debugging, and post-processing analysis all require specialized expertise. Second, high computational costs: large-scale system simulations rely on high-performance computing clusters, with single simulations often taking days. Third, difficult data management: massive trajectory data lack standardized storage and reuse mechanisms. These issues have long confined traditional MD to the realm of specialized tools.

The deep penetration of AI technology is systematically breaking through the above bottlenecks.

II. Deep Integration of AI: Four Core Upgrades of Molecular Dynamics Platforms

Upgrade 1: AI Machine Learning Force Fields, Balancing Accuracy and Efficiency

Natural Language to Atomic Simulation Pipeline

Traditional MD simulations rely on empirical force fields—interatomic interaction parameters fitted from experimental data—which have limited accuracy and struggle to precisely describe complex systems such as chemical reactions. The emergence of Machine Learning Force Fields (MLFF) offers a new technical pathway—neural networks directly learn potential energy surfaces from high-precision quantum chemical calculation data, achieving predictive accuracy comparable to Density Functional Theory (DFT) within the coverage of training data, while being 3 to 6 orders of magnitude more computationally efficient than DFT.

A domestic cloud-based atomic simulation platform integrates generalized global neural network potential functions covering multiple elements, achieving DFT-level accuracy with high computational efficiency. The platform enables fully automated workflows from material structure generation to potential energy surface exploration through a web-based graphical interface, allowing researchers without programming backgrounds to independently perform high-precision simulation tasks.

Upgrade 2: Natural Language Interaction, Enabling Low-Code Intelligent Simulation

Traditional MD simulation workflows are cumbersome, requiring proficiency in command-line operations and script debugging. Next-generation platforms leverage large language models to restructure operational workflows, enabling natural language-driven simulation automation.

A simulation platform developed by a domestic research team deeply integrates with mainstream molecular dynamics workflows such as LAMMPS and ReaxFF MD, combining natural language interaction, file management, code generation, solver execution, log inspection, and result visualization into a unified workspace. Researchers need only describe their simulation requirements in natural language, and the platform autonomously completes the entire workflow of modeling, parameter configuration, simulation execution, and data processing.

Upgrade 3: Multi-Agent Collaboration, End-to-End Autonomous Simulation

Traditional MD workflows are highly fragmented, with structure preprocessing, force field selection, parameter setting, simulation monitoring, and data analysis scattered across different software, resulting in extremely high manual switching costs. The deployment of multi-agent AI frameworks effectively addresses this pain point.

A modular multi-agent simulation framework for biomolecular systems can complete full-process MD simulations of proteins and protein-ligand complexes with limited human intervention, supporting MM/PB(GB) SA methods for binding free energy and affinity calculations. The framework integrates dynamic tool invocation, intelligent retrieval, and self-correction capabilities, relying on the collaboration of three agents—experimental planning, simulation execution, and data analysis—to complete simulation scheme design, model execution, and result interpretation in a one-stop manner.

Upgrade 4: Conversational AI Platforms, Bridging Molecular Simulation and Protein Design

The three upgrades above address the accuracy, efficiency, and automation challenges of MD simulations. However, simulation itself is not the ultimate goal—researchers' core need is to guide protein design and engineering through simulation. MatwingsVenus™ （晓鹜™）, independently developed by Matwings, exemplifies the integration of molecular simulation capabilities into the full protein R&D pipeline.

According to the company's official website, this is an agent-centric conversational protein R&D platform. Users propose functional requirements in natural language, and after AI completes sequence design, the platform can invoke molecular dynamics simulation modules to validate and evaluate the conformational stability and dynamic behavior of mutants, while automatically interfacing with automated laboratories to drive robots through key experimental steps including sample preparation, protein purification, and functional assays. Experimental results can then undergo multiple rounds of efficient AI-driven iterative optimization, achieving a full-process "conversational dry-wet closed loop" for intelligent R&D.

The platform supports retrieval from billions of real-labeled protein data points, integrating over 200 protein design tools, more than 50 platform-certified experts, and over 30 domain-expert-tuned Skills. As disclosed on the Matwings official website in June 2026, the platform added three core models—BoltzGen, LigandMPNN, and Protenix—to its "Protein Generation" module, continuously expanding the boundaries of molecular simulation and protein design capabilities.

III. Covering Drug Discovery, Biomanufacturing, and Advanced Materials

Quantum Chemistry to Neural Force Field Pipeline

With AI empowerment, molecular dynamics platforms are transitioning from academic research to industrialization, becoming core digital tools for drug discovery, industrial biomanufacturing, and advanced materials development.

In drug discovery, MD simulation has become a standard tool for innovative pharmaceutical companies. By simulating the dynamic binding process between drug molecules and target proteins, researchers can elucidate binding mechanisms, predict binding free energies, and assess the druggability of candidate molecules. Cutting-edge AI models accelerate force calculations through neural network force fields, improving molecular simulation efficiency by several orders of magnitude in specific scenarios.

The application of Matwings' MatwingsVenus™ （晓鹜™） platform in innovative drug development has been validated through real projects. According to official disclosures, in a de novo design project targeting an immune checkpoint receptor, the platform successfully generated dozens of novel binder molecules with in vitro cell-based blocking activity. The target presented unique challenges—limited precedents, a predominantly polar surface lacking typical binding hot spots, and a natural ligand with nM-level high affinity—making the design exceptionally difficult. Leveraging the platform, agents automatically completed scaffold screening, interface design, sequence optimization, and drug-like property prediction, with samples prepared through automated experiments demonstrating outstanding performance in vitro.

In industrial enzyme engineering and biomanufacturing, molecular dynamics platforms can simulate the conformational evolution of enzyme proteins under extreme industrial conditions (high temperature, strong acid, strong base), providing atomic-level theoretical foundations for evaluating structural stability. A domestic platform has been successfully applied to esterification reaction studies, compressing reaction pathway scanning and energy barrier evaluation from days using traditional DFT to hours, with key-site energies highly consistent with DFT results.

Matwings' MatwingsVenus™ （晓鹜™） platform already supports two core functions—"AI-directed evolution" and "AI enzyme discovery"—breaking through the traditional "sequence-structure-function" prediction paradigm to achieve closed-loop design from functional requirements to primary sequences. According to official data, the platform compresses the traditional 2-to-5-year enzyme R&D cycle to 2 to 6 months, with over 40 protein design projects delivered.

In advanced materials, molecular dynamics platforms are penetrating deeply into areas such as new energy battery materials, high-performance alloys, and catalytic materials. A domestic platform can invoke reactive molecular dynamics workflows to precisely simulate atomic-level reorganization and bond-breaking processes during the thermal decomposition of energetic materials. High-performance software packages deeply integrate with machine learning potential functions, supporting system simulations ranging from tens of thousands to hundreds of thousands of atoms.

IV. Current Challenges in the Industry

The integration of AI and molecular dynamics is still in its early industrialization stages. First, machine learning force fields are highly dependent on training data quality and coverage—datasets for rare elements and extreme conditions remain scarce, limiting model generalization. Second, natural language-driven simulations only work for standardized conventional systems; complex custom reactions and multi-scale coupling scenarios still require manual parameter tuning. Third, multi-agent frameworks still have relatively low self-correction efficiency when encountering structural anomalies or simulation errors. Fourth, AI force field simulations demand substantial GPU computing resources, creating entry barriers for small and medium-sized teams.

V. Future Trends

Molecular dynamics platforms are in a critical transition from "computational aids" to "AI-native simulation infrastructure," with three major trends reshaping the industry landscape.

Trend 1: Large-scale application of AI force fields. Machine learning force field technology continues to evolve, transitioning from academic research to industrial deployment. In the future, it will become the mainstream simulation approach for complex scenarios such as chemical reactions and multi-element composite systems. Traditional empirical force fields, with their low cost and high stability, will continue to serve routine simulations, with the two technologies remaining complementary in the long term.

Trend 2: Zero-code, full automation becoming standard. Practices represented by multiple domestic natural language-driven simulation platforms have validated technical feasibility. As large language model capabilities continue to advance, researchers will be able to complete full simulation workflows simply by describing requirements in natural language.

Trend 3: Deep integration of dry and wet experiments. Molecular dynamics simulation is increasingly establishing data links with automated experimental platforms, building a positive closed loop of "simulation prediction—experimental validation—data iteration," enabling bidirectional empowerment between simulation and experimentation.

VI. Conclusion

Molecular dynamics platforms are reshaping the logic of atomic-scale research, driving the industry from an experiencebased trial-and-error paradigm of "experiment first, analyze later" to a data-driven paradigm of "simulate first, validate later." From cloud-based atomic simulations driven by machine learning force fields, to intelligent simulation workbenches with natural language interaction; from multi-agent autonomous simulation frameworks, to conversational protein R&D platforms like MatwingsVenus™ （晓鹜™）—these breakthroughs collectively point toward a trend: AI-native molecular dynamics platforms are demonstrating their potential as core digital infrastructures for atomic-world R&D, providing critical digital foundations for synthetic biology, innovative drug discovery, and advanced new materials industries.